Combining hormonal therapy and tirzepatide may lead to the greatest weight loss after menopause, new evidence suggests.

A new study found that a combination of hormone therapy and the GLP-1 medication tirzepatide (Zepbound) led to 35% more ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

A prevention strategy developed by Canadian researchers can reduce the risk of the most common and deadly form of ovarian cancer by nearly 80 per cent. The strategy, known as opportunistic ...

Heart specialists at Mayo Clinic today presented new research at the 2026 Society of Thoracic Surgeons Annual Meeting that ...

Alterome Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the development of next-generation, small molecule targeted therapies for the treatment of cancer, today announced ...

Dr. John R. Crockarell Elected Chief of Staff, Succeeding Dr. Frederick M. Azar Dr. Crockarell embodies the Clinic’s ...

Mayo Clinic researchers have developed a pioneering method to mend damaged hearts without open-heart surgery, an advance that could one day transform the treatment of heart failure ...

Experts say the key lies in the cough’s symptoms and length. People should go see a doctor if their cough lasts for more than a week or a couple of weeks. “We’re especially concerned when a cough ...

Heart specialists at Mayo Clinic today presented new research at the 2026 Society of Thoracic Surgeons Annual Meeting that redo surgery for adults with congenital heart disease (CHD) remains high-risk ...

Read about the backgrounds and research interests of team members in Dr. Grinberg's Neurodegeneration and Sleep Pathology Lab at Mayo Clinic.

Dr. Stuart Himmelstein, DC, a Philadelphia-based chiropractor, examines how peripheral neuropathy is evaluated in ...